A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury*

2011172 citationsJournal Articlegreen Open Access

Authors

Renee D. Stapleton · University of Vermont

Thomas R. Martin · University of Washington

Noel S. Weiss · University of Washington

Joseph J. Crowley · CancerCare

Stephanie Gundel · University of Washington

Avery B. Nathens · University of Toronto

Saadia Akhtar ·

Abstract

Fish oil did not reduce biomarkers of pulmonary or systemic inflammation in patients with acute lung injury, and the results do not support the conduct of a larger clinical trial in this population with this agent. This experimental approach is feasible for proof-of-concept studies evaluating new treatments for acute lung injury.

Topics & Keywords

Respiratory Support and Mechanisms Clinical Nutrition and Gastroenterology Neonatal Respiratory Health Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Critical Care Medicine

Volume 39, Issue 7, pp. 1655-1662

DOI: 10.1097/ccm.0b013e318218669d

Field-Weighted Citation Impact: 14.67